| Literature DB >> 34260040 |
Anna Viljanen1,2, Marika Salminen3,4, Kerttu Irjala5, Elisa Heikkilä5, Raimo Isoaho4,6, Sirkka-Liisa Kivelä4,7, Päivi Korhonen4, Tero Vahlberg8, Matti Viitanen9,10, Maarit Wuorela9,3, Minna Löppönen11, Laura Viikari9,3.
Abstract
PURPOSE: The ageing population is increasingly multimorbid. This challenges health care and elderly services as multimorbidity is associated with institutionalization. Especially dementia increases with age and is the main risk factor for institutionalization. The aim of this study was to assess the association of chronic conditions and multimorbidity with institutionalization in home-dwelling older people, with and without dementia.Entities:
Keywords: Aged; Institutionalization; Multimorbidity; Multiple chronic conditions
Mesh:
Year: 2021 PMID: 34260040 PMCID: PMC8626405 DOI: 10.1007/s41999-021-00535-y
Source DB: PubMed Journal: Eur Geriatr Med ISSN: 1878-7649 Impact factor: 1.710
Baseline characteristics of study participants according to institutionalization (n = 820)
| Institutionalized | Not institutionalized | ||
|---|---|---|---|
| aAge, years | 75.3 (6.5) [64‒95] | 74.2 (6.9) [64‒97] | 0.008 |
| Age, years | 0.073 | ||
| 64–74 | 163 (50) | 284 (58) | |
| 75–84 | 134 (41) | 166 (34) | |
| ≥ 85 | 31 (9) | 42 (9) | |
| Gender | < 0.001 | ||
| Men | 105 (32) | 252 (51) | |
| Women | 223 (68) | 240 (49) | |
| Living | 0.001 | ||
| Alone | 140 (43) | 153 (31) | |
| With someone | 188 (57) | 339 (69) | |
| bMMSE | 0.002 | ||
| ≥ 26 | 247 (75) | 413 (84) | |
| < 26 | 81 (25) | 79 (16) |
Baseline examination between March 1998 and September 1999
aValues are mean (standard deviation) [range]
bMini-Mental State Examination
Participants according to chronic conditions, multimorbidity and institutionalization (n = 820)
| Chronic conditions | Institutionalized | Not institutionalized | |
|---|---|---|---|
| Malignant neoplasms (except basal cell carcinomas) | 74 (23) | 212 (43) | < 0.001 |
| Iron deficiency anaemia | 39 (12) | 57 (12) | 0.894 |
| B12-vitamin anaemia | 23 (7) | 40 (8) | 0.556 |
| Hypothyroidism | 47 (14) | 48 (10) | 0.045 |
| Diabetes mellitus | 78 (24) | 125 (25) | 0.597 |
| Hypercholesterolaemia | 114 (35) | 174 (35) | 0.858 |
| Dementia | 230 (70) | 104 (21) | < 0.001 |
| Mood disorders | 150 (46) | 104 (21) | < 0.001 |
| aSystemic atrophies, extrapyramidal and movement disorders | 40 (12) | 30 (6) | 0.002 |
| Hypertension | 198 (60) | 290 (59) | 0.684 |
| Ischemic heart disease | 169 (52) | 302 (61) | 0.005 |
| Atrial fibrillation | 98 (30) | 184 (37) | 0.026 |
| Intracranial haemorrhage | 17 (5) | 23 (5) | 0.740 |
| Stroke | 124 (38) | 159 (32) | 0.105 |
| Atherosclerosis | 23 (7) | 54 (11) | 0.057 |
| Chronic lower respiratory diseases | 62 (19) | 124 (25) | 0.035 |
| Renal failure | 33 (10) | 77 (16) | 0.021 |
| bMultimorbidity3 + | 293 (89) | 406 (83) | 0.007 |
| bMultimorbidity4 + | 244 (74) | 333 (68) | 0.039 |
| bMultimorbidity5 + | 168 (51) | 213 (43) | 0.026 |
| bMultimorbidity6 + | 96 (29) | 116 (26) | 0.068 |
aReferred to as neurological disorders in the main text
bThe number signifies the number of chronic conditions used as a cut-off for multimorbidity; multimorbidity3 + denotes three or more chronic conditions, multimorbidity4 + denotes four or more chronic conditions, multimorbidity5 + denotes five or more chronic conditions and multimorbidity6 + denotes six or more chronic conditions
Fig. 1Participants (not institutionalized and institutionalized) according to their number of chronic conditions (n = 820). Percentages of participants with each number of chronic conditions in either category [not institutionalized (n = 492) or institutionalized (n = 328)] are shown in parentheses
Institutionalized participants according to dementia and other chronic conditions (n = 328)
| Chronic condition | With dementia | Without dementia | |
|---|---|---|---|
| Malignant neoplasms (except basal cell carcinomas) | 42 (18) | 32 (33) | 0.004 |
| Iron deficiency anaemia | 24 (10) | 15 (15) | 0.212 |
| B12-vitamin anaemia | 14 (6) | 9 (9) | 0.315 |
| Hypothyroidism | 37 (16) | 10 (10) | 0.164 |
| Diabetes mellitus | 50 (22) | 28 (29) | 0.183 |
| Hypercholesterolaemia | 86 (37) | 28 (29) | 0.125 |
| Mood disorders | 105 (46) | 45 (46) | 0.965 |
| aSystemic atrophies, extrapyramidal and movement disorders | 23 (10) | 17 (17) | 0.063 |
| Hypertension | 136 (59) | 62 (63) | 0.484 |
| Ischemic heart disease | 120 (52) | 49 (50) | 0.718 |
| Atrial fibrillation | 66 (29) | 32 (33) | 0.474 |
| Intracranial haemorrhage | 10 (4) | 7 (7) | 0.296 |
| Stroke | 86 (37) | 38 (39) | 0.813 |
| Atherosclerosis | 13 (6) | 10 (10) | 0.140 |
| Chronic lower respiratory diseases | 41 (18) | 21 (21) | 0.446 |
| Renal failure | 23 (10) | 10 (10) | 0.955 |
| bMultimorbidity3 + | 212 (92) | 81 (83) | 0.011 |
| bMultimorbidity4 + | 178 (77) | 66 (67) | 0.018 |
| bMultimorbidity5 + | 128 (56) | 40 (41) | 0.005 |
| bMultimorbidity6 + | 76 (33) | 20 (20) | 0.007 |
aReferred to as neurological disorders in the main text
bThe number signifies the number of chronic conditions used as a cut-off for multimorbidity; multimorbidity3 + denotes three or more chronic conditions, multimorbidity4 + denotes four or more chronic conditions, multimorbidity5 + denotes five or more chronic conditions and multimorbidity6 + denotes six or more chronic conditions
Association of chronic conditions and multimorbidity with institutionalization during the 18-year follow-up (n = 820)
| Chronic conditions | All participants ( | Participants without dementia ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted HR | aAdjusted HR | Unadjusted HR | aAdjusted HR | |||||
| Malignant neoplasms (except basal cell carcinomas) | 0.46 (0.36‒0.60) | < 0.001 | 0.51 (0.40‒0.67) | < 0.001 | 0.58 (0.38‒0.89) | 0.013 | 0.62 (0.40‒0.95) | 0.029 |
| Iron deficiency anaemia | 1.01 (0.73‒1.41) | 0.955 | 0.98 (0.70‒1.36) | 0.900 | 1.23 (0.72‒2.09) | 0.455 | 1.12 (0.65‒1.92) | 0.681 |
| B12-vitamin anaemia | 0.88 (0.58‒1.35) | 0.561 | 0.75 (0.48‒1.19) | 0.229 | 1.01 (0.51‒1.99) | 0.981 | 0.86 (0.41‒1.77) | 0.674 |
| Hypothyroidism | 1.42 (1.04‒1.93) | 0.030 | 1.21 (0.87‒1.70) | 0.250 | 1.02 (0.54‒1.94) | 0.953 | 0.82 (0.43‒1.59) | 0.560 |
| Diabetes mellitus | 0.93 (0.72‒1.20) | 0.585 | 0.95 (0.73‒1.23) | 0.686 | 1.05 (0.68‒1.62) | 0.825 | 1.10 (0.71‒1.70) | 0.661 |
| Hypercholesterolaemia | 0.93 (0.75‒1.17) | 0.540 | 0.88 (0.70‒1.12) | 0.294 | 0.81 (0.52‒1.25) | 0.333 | 0.72 (0.46‒1.12) | 0.140 |
| Dementia | 4.84 (3.80‒6.16) | < 0.001 | 4.73 (3.69‒6.05) | < 0.001 | ||||
| Mood disorders | 2.31 (1.86‒2.87) | < 0.001 | 2.00 (1.58‒2.52) | < 0.001 | 2.92 (1.97‒4.34) | < 0.001 | 2.69 (1.77‒4.10) | < 0.001 |
| bSystemic atrophies, extrapyramidal and movement disorders | 1.71 (1.24‒2.37) | 0.001 | 1.97 (1.41‒2.77) | < 0.001 | 2.74 (1.59‒4.72) | < 0.001 | 3.31 (1.85‒5.91) | < 0.001 |
| Hypertension | 0.97 (0.78‒1.22) | 0.804 | 0.97 (0.76‒1.23) | 0.781 | 1.04 (0.69‒1.58) | 0.844 | 1.03 (0.66‒1.59) | 0.913 |
| Ischemic heart disease | 0.75 (0.61‒0.93) | 0.010 | 0.73 (0.58‒0.91) | 0.005 | 0.65 (0.44‒0.96) | 0.032 | 0.63 (0.43‒0.94) | 0.025 |
| Atrial fibrillation | 0.75 (0.59‒0.95) | 0.015 | 0.77 (0.60‒0.98) | 0.030 | 0.76 (0.50‒1.16) | 0.205 | 0.75 (0.49‒1.14) | 0.181 |
| Intracranial haemorrhage | 1.07 (0.66‒1.74) | 0.771 | 1.11 (0.68‒1.83) | 0.672 | 1.48 (0.69‒3.16) | 0.314 | 1.43 (0.67‒3.06) | 0.351 |
| Stroke | 1.21 (0.96‒1.51) | 0.101 | 1.14 (0.91‒1.45) | 0.257 | 1.35 (0.90‒2.03) | 0.146 | 1.35 (0.89‒2.03) | 0.160 |
| Atherosclerosis | 0.68 (0.44‒1.04) | 0.077 | 0.76 (0.49‒1.16) | 0.199 | 1.04 (0.54‒1.99) | 0.910 | 1.20 (0.62‒2.32) | 0.591 |
| Chronic lower respiratory diseases | 0.75 (0.57‒1.00) | 0.041 | 0.80 (0.60‒1.07) | 0.127 | 0.82 (0.51‒1.32) | 0.406 | 0.88 (0.54‒1.43) | 0.616 |
| Renal failure | 0.65 (0.45‒0.92) | 0.015 | 0.67 (0.47‒0.96) | 0.028 | 0.58 (0.31‒1.11) | 0.101 | 0.56 (0.29‒1.08) | 0.084 |
| cMultimorbidity3 + | 1.50 (1.04‒2.16) | 0.032 | 1.31 (0.90‒1.91) | 0.165 | 1.11 (0.65‒1.90) | 0.713 | 0.96 (0.55‒1.66) | 0.879 |
| cMultimorbidity4 + | 1.25 (0.97‒1.60) | 0.087 | 1.14 (0.87‒1.48) | 0.340 | 1.08 (0.71‒1.65) | 0.728 | 0.98 (0.64‒1.51) | 0.917 |
| cMultimorbidity5 + | 1.26 (1.01‒1.56) | 0.037 | 1.25 (1.00‒1.56) | 0.0498 | 1.05 (0.70‒1.57) | 0.802 | 1.05 (0.70‒1.58) | 0.799 |
| cMultimorbidity6 + | 1.20 (0.95‒1.52) | 0.120 | 1.19 (0.93‒1.52) | 0.159 | 0.91 (0.56‒1.47) | 0.685 | 0.90 (0.54‒1.47) | 0.662 |
HR Hazard ratio, CI Confidence interval
aAdjusted for age, gender, living situation, and MMSE score
bReferred to as neurological disorders in the main text
cThe number signifies the number of chronic conditions used as a cut-off for multimorbidity; multimorbidity3 + denotes three or more chronic conditions, multimorbidity4 + denotes four or more chronic conditions, multimorbidity5 + denotes five or more chronic conditions and multimorbidity6 + denotes six or more chronic conditions